| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥501.4B | ¥489.0B | +2.5% |
| Operating Income | ¥19.4B | ¥17.1B | +13.3% |
| Ordinary Income | ¥23.7B | ¥20.6B | +15.1% |
| Net Income | ¥18.5B | ¥18.5B | +0.1% |
| ROE | 5.6% | 6.3% | - |
FY2026 Q3 results showed revenue growth with stronger profit expansion: Revenue 50.1B yen (YoY +2.5%), Operating Income 1.9B yen (+13.3%), Ordinary Income 2.4B yen (+15.1%), and Net Income 1.8B yen (+0.1%). The Chemical segment drove steady growth with new municipal water treatment contracts and electronics industry demand, while the Functional Materials segment benefited from overseas packaging equipment orders. Operating margin improved to 3.9% from 3.5% YoY, though profitability remains modest in absolute terms. Non-operating income of 0.5B yen (mainly dividend income 0.5B yen) and extraordinary gains from investment securities sales (0.4B yen) contributed to ordinary income exceeding operating income by 22.5%. Total assets expanded to 83.8B yen (+14.5% YoY) driven by investment securities appreciation (+27.3%) and trade receivables growth (+12.4%), while equity increased to 33.0B yen with comprehensive income reaching 4.4B yen due to valuation gains on securities.
Revenue growth of +2.5% was driven by the Chemical segment's new municipal aluminum compound contracts for water treatment and robust demand for electronics-grade caustic soda and inorganic chemicals, along with strong sales of toiletry-related products to consumer goods and pet product industries. The Functional Materials segment contributed with overseas packaging equipment orders and expanded sales of composite films for food packaging applications. The Other segment saw a notable recovery in textile accessories transactions through consolidated subsidiary Morris Co.
Operating income increased +13.3%, outpacing revenue growth due to improved cost absorption and SG&A expense control (SG&A grew approximately +3.0%, below revenue growth). Gross profit margin improved to 14.4% from prior year levels, though it remains structurally low for the trading industry. Operating margin reached 3.9%, up 0.4pt YoY, reflecting operational leverage from volume growth.
The gap between operating income (1.9B yen) and ordinary income (2.4B yen) of 0.4B yen (+22.5%) stems from non-operating income of 0.5B yen, primarily dividend income of 0.5B yen from investment securities holdings. Investment securities sales generated extraordinary gains of 0.4B yen, but this was a non-recurring factor. The effective tax rate of 33.1% and tax burden coefficient of 0.668 compressed net income to 1.8B yen, resulting in flat YoY growth (+0.1%) despite strong ordinary income expansion.
This represents a "revenue up, profit up" pattern with operating leverage driving margin expansion, though net income growth was constrained by reduced extraordinary gains compared to prior year and normal tax burden.
Chemical segment is the core business accounting for 66.7% of total revenue and generated sales of 33.5B yen (+1.9%) with operating income of 2.9B yen (+2.6%), maintaining an operating margin of 8.7%. Growth drivers included new municipal contracts for aluminum compound-based water treatment chemicals, increased transactions of electronics-grade caustic soda and inorganic chemicals to the electronics industry, and expanded sales of toiletry-related products to consumer goods and pet product manufacturers. This segment provided stable profit contribution with consistent margin performance.
Functional Materials segment recorded sales of 11.5B yen (+5.2%) and operating income of 0.6B yen (+4.2%), representing a 5.9% operating margin. Revenue growth outpaced the Chemical segment, driven by overseas orders for packaging-related equipment, robust sales of composite films for food packaging applications, and increased orders for machine tool components. However, short glass fiber products faced order declines in transportation equipment applications, partially offsetting growth. This segment showed the strongest revenue growth momentum among all segments.
Other segment posted sales of 6.0B yen (+1.5%) with operating income of 0.2B yen (+48.8%), achieving a 3.6% margin that improved significantly from prior year. The substantial profit increase was driven by strong textile accessories transactions at domestic consolidated subsidiary Morris Co. In contrast, Indonesian operations struggled with chemical product sales due to economic slowdown and intensifying competitive environment. Despite its smaller scale, this segment delivered the highest operating profit growth rate at +48.8%.
The Chemical segment as the core business drove overall stability with its large profit base (2.9B yen), while the Functional Materials segment provided growth momentum with +5.2% revenue expansion. The Other segment's profit surge (+48.8%) added positive leverage despite representing only 11.9% of total sales.
Profitability: ROE 5.6% (PY estimated at approximately 6.3% based on profit levels and lower equity base), Operating Margin 3.9% (PY 3.5%), Net Profit Margin 3.7% (stable YoY), Gross Profit Margin 14.4% (improved from prior year but structurally low for trading sector). ROIC of 4.7% signals capital efficiency concerns.
Efficiency: Asset Turnover 0.60x (declined from higher prior levels due to asset base expansion outpacing revenue growth). ROA 2.2% reflects modest asset productivity.
Financial Health: Equity Ratio 39.4% (PY 40.4%), Current Ratio 128.4%, Quick Ratio 125.0% indicate adequate short-term liquidity. Financial Leverage 2.54x (PY approximately 2.48x) increased slightly with asset expansion. Cash and deposits of 9.0B yen cover short-term debt of 3.7B yen by 2.45x, ensuring near-term payment capacity. However, short-term debt represents 100% of interest-bearing debt, creating refinancing concentration risk.
Investment: Investment securities increased to 17.6B yen (+27.3%), representing 21.0% of total assets. This holding generates dividend income but introduces mark-to-market volatility risk. Capital expenditure and depreciation data not disclosed in available XBRL.
Working Capital: Trade receivables of 46.8B yen represent 55.8% of total assets with an estimated DSO of approximately 340 days, signaling severe collection delays or extended credit terms that tie up capital and threaten cash conversion. This is the most critical operational risk factor.
Operating CF data is not disclosed in available XBRL, preventing direct assessment of cash generation quality. The absence of operating CF transparency limits evaluation of whether reported earnings are converting to cash.
Investing CF composition is partially observable through balance sheet changes: investment securities increased by 3.8B yen, indicating continued investment activity. Cash and deposits increased by 1.7B yen, suggesting positive net cash flow during the period.
Financing CF indicators: dividends were paid (interim 17.0 yen per share declared), and treasury stock decreased slightly from -0.2B yen to -0.1B yen (+27.7%), suggesting minor share repurchase activity or disposal.
FCF cannot be calculated without operating CF and capex disclosure. However, the significant increase in trade receivables (+5.2B yen) and investment securities (+3.8B yen) likely absorbed substantial cash, potentially offsetting operating cash generation.
Cash generation quality requires monitoring given the structural concern: net income of 1.8B yen may not be fully converting to operating cash if the 46.8B yen receivables balance with 340-day DSO reflects delayed collections. Until operating CF data is disclosed, earnings quality remains uncertain despite reported profit growth.
Ordinary Income of 2.4B yen exceeded Operating Income of 1.9B yen by 0.4B yen (+22.5%), attributable to non-operating income of 0.5B yen. The primary component is dividend income of 0.5B yen from investment securities holdings, which represents a recurring source given the company's sustained securities portfolio.
Net Income of 1.8B yen fell short of Ordinary Income by 0.5B yen due to extraordinary items and tax burden. Extraordinary gains included 0.4B yen from investment securities sales, a non-recurring factor that was lower than prior year levels, explaining why net income growth (+0.1%) significantly lagged ordinary income growth (+15.1%). This gain constitutes 2.3% of net income and 0.8% of revenue, making it material but not dominant.
Earnings quality concern: Trade receivables of 46.8B yen with an estimated DSO of 340 days represent a severe accrual quality issue. If earnings are being recognized on sales with such extended collection periods, there is high risk that reported profits are not converting to cash. This creates an accrual-based earnings quality red flag, as revenue recognition may be outpacing actual cash realization.
The lack of operating CF disclosure prevents direct comparison of Operating CF to Net Income. A healthy ratio would exceed 1.0x, confirming cash-backed earnings. Without this data point, investors must rely on balance sheet working capital trends, which show deteriorating receivables turnover—a negative quality signal.
Overall, core operating earnings quality appears reasonable with steady Chemical segment performance, but the combination of (1) material extraordinary gains, (2) extreme receivables buildup, and (3) absent operating CF transparency raises moderate earnings quality concerns requiring close monitoring.
Full-year guidance remains unchanged from initial forecast: Revenue 70.5B yen, Operating Income 2.3B yen, Ordinary Income 2.7B yen, Net Income 2.3B yen. Q3 cumulative progress rates are: Revenue 71.1% (50.1B yen / 70.5B yen), Operating Income 82.7% (1.9B yen / 2.3B yen), Ordinary Income 88.2% (2.4B yen / 2.7B yen), Net Income 80.3% (1.8B yen / 2.3B yen).
Against standard quarterly pacing (Q3 = 75%), revenue progress is slightly behind at 71.1% (delta -3.9pt), suggesting Q4 requires 19.4B yen in sales versus Q3's 50.1B yen cumulative (implying Q4 alone needs material acceleration). Operating Income progress of 82.7% is ahead of standard pacing (+7.7pt), indicating conservative full-year guidance or front-loaded profitability. Ordinary Income at 88.2% is significantly ahead (+13.2pt), likely due to the timing of dividend income and securities gains. Net Income progress of 80.3% is moderately ahead (+5.3pt).
The ahead-of-pace profit metrics suggest the full-year guidance is achievable and potentially conservative. However, revenue progress slightly trailing standard pacing indicates Q4 sales acceleration is needed to meet the 70.5B yen target. The company has not revised guidance, signaling confidence in Q4 performance driven by continued strength in municipal water treatment contracts, electronics industry demand, and overseas packaging equipment orders as cited in PDF materials.
Key drivers for achieving guidance include: sustained Chemical segment transaction volumes, realization of booked Functional Materials overseas orders, and absence of major market disruptions. Risks include potential receivables collection issues (given the 340-day DSO) affecting revenue recognition timing, and macroeconomic headwinds in Indonesia impacting Other segment performance.
The company forecasts an annual dividend of 20.0 yen per share for FY2026 (interim and year-end each 20.0 yen per share based on disclosed dividend policy). Based on full-year forecast net income of 2.3B yen and approximately 22.8 million shares outstanding (derived from EPS guidance of 101.01 yen), total dividend payout would approximate 0.5B yen, resulting in a payout ratio of approximately 21.8% on forecast earnings.
However, XBRL data indicates interim dividend of 17.0 yen and year-end dividend of 23.0 yen were declared, totaling 40.0 yen per share for the fiscal year. Against Q3 cumulative net income of 1.8B yen and assuming 22.8 million shares, this implies a total dividend of approximately 0.9B yen and a payout ratio of approximately 49.7% based on Q3 actual earnings. This discrepancy suggests either updated dividend decisions or timing differences in reporting.
Management's stated policy targets a dividend payout ratio of 40% or above as part of the medium-term business plan "Go forward STAGE3," emphasizing consistent shareholder returns. The calculated 49.7% payout on Q3 earnings aligns with this policy framework.
Dividend sustainability: Cash and deposits of 9.0B yen and low interest-bearing debt of 3.7B yen provide adequate liquidity to support dividend payments. However, the absence of disclosed operating CF and the severe receivables buildup (DSO 340 days) raise questions about whether operating earnings are generating sufficient cash to fund dividends sustainably. If receivables are not converting to cash, future dividend capacity could be constrained despite reported profitability.
No share buyback activity was disclosed in materials, indicating shareholder returns are currently dividend-focused. The total return ratio equals the payout ratio at approximately 49.7% based on Q3 results, within sustainable range for a trading company with stable cash generation—though operating CF transparency is needed to confirm this assessment.
Near-term: (1) Q4 revenue acceleration needed to achieve full-year target of 70.5B yen, with focus on Chemical segment municipal contracts and Functional Materials overseas orders executing on schedule. (2) Receivables collection improvement to address the 340-day DSO, which if successfully reduced would significantly enhance operating cash flow and validate earnings quality. (3) Stability in investment securities valuations, as the 17.6B yen portfolio represents 21% of assets and mark-to-market fluctuations directly impact comprehensive income and equity.
Long-term: (1) Expansion of municipal water treatment chemical contracts beyond current customer base, leveraging successful new aluminum compound product introductions. (2) Sustained growth in electronics industry demand for caustic soda and inorganic chemicals as semiconductor and electronics manufacturing activity continues. (3) Overseas market penetration for packaging-related equipment in the Functional Materials segment, building on Q3's successful order intake. (4) Structural margin improvement through product mix optimization toward higher-value chemicals and functional materials, addressing the current low gross margin of 14.4%. (5) Capital efficiency enhancement to lift ROIC above 4.7%, requiring either higher profit margins, faster asset turnover, or more disciplined working capital management. (6) Resolution of Indonesian market challenges in the Other segment through strategic repositioning or market recovery.
Industry Position (Reference - Proprietary Analysis)
Profitability: Operating Margin 3.9% (Industry Median 3.2% for 2025-Q3), Net Profit Margin 3.7% (Industry Median 2.0%), ROE 5.6% (Industry Median 3.7%), ROA 2.2% (Industry Median 2.3%). The company's operating and net profit margins exceed industry median, indicating relatively better cost control and profitability conversion. However, ROE slightly above median reflects the benefit of higher financial leverage (2.54x vs. industry median 1.97x) rather than superior asset efficiency.
Efficiency: Asset Turnover 0.60x (Industry Median 1.06x), significantly underperforming the industry standard. This gap is the company's most critical competitive weakness, driven by the extreme receivables buildup (DSO estimated 340 days vs. industry median receivables turnover of 74 days). ROIC 4.7% (Industry Median 3.0% for 2025-Q3) is above median but remains in low single digits, indicating modest capital productivity.
Financial Health: Equity Ratio 39.4% (Industry Median 47.8%), below industry median and reflecting higher leverage. Current Ratio 128.4% (Industry Median 188.0%) is notably lower, suggesting tighter liquidity compared to trading peers, though still adequate. Financial Leverage 2.54x (Industry Median 1.97x) confirms higher debt utilization.
Growth: Revenue Growth YoY +2.5% (Industry Median +2.6% for 2025-Q3), in line with industry pace. The company is growing at market rate without significant outperformance or underperformance.
Working Capital: Receivables Turnover estimated 340 days substantially worse than Industry Median of 74 days, representing the company's most significant operational deficiency. Operating Working Capital Turnover days would likely exceed industry median of 54 days given this receivables drag. Inventory and payables data not disclosed for full comparison.
Overall positioning: Soda Nikka demonstrates above-median profitability margins but suffers from severely below-median asset turnover, creating a "high margin, low turnover" profile within the trading industry. The company's leverage is higher than peers, supporting ROE but increasing financial risk. The most urgent competitive gap is working capital efficiency, particularly receivables management, where the company lags industry standards by a multiple of 4-5x. Addressing this would unlock substantial cash generation and improve capital efficiency toward industry-leading levels.
Industry: Trading (N=15 companies), Comparison Period: 2025-Q3, Source: Proprietary analysis
(1) Working Capital Deterioration Risk: Trade receivables of 46.8B yen with estimated DSO of 340 days represent 55.8% of total assets and approximately 9.3x quarterly revenue, indicating severe collection delays or extended credit terms. If customers face financial distress or payment delays extend further, the company faces material cash flow pressure and potential bad debt losses. This is the highest priority risk given its magnitude and direct impact on liquidity and earnings quality. Quantified impact: each 30-day improvement in DSO would release approximately 4B yen in cash.
(2) Investment Securities Mark-to-Market Risk: Investment securities holdings of 17.6B yen (+27.3% YoY) represent 21.0% of total assets and 53.2% of equity. These holdings generated 0.5B yen in dividend income (27% of ordinary income) and 0.4B yen in realized gains, but also expose the company to mark-to-market volatility. A 10% market decline would reduce asset value by 1.8B yen and comprehensive income by a similar amount, representing 5.3% of equity. This risk is elevated by the securities' weighting in the balance sheet.
(3) Refinancing and Interest Rate Risk: Short-term debt of 3.7B yen represents 100% of interest-bearing debt, creating refinancing concentration risk. While currently covered 2.45x by cash, this structure is vulnerable to credit market tightening or rising interest rates. Additionally, total liabilities of 50.8B yen include significant current liabilities (39.6B yen), indicating reliance on short-term funding. A 100bp rise in borrowing costs would increase annual interest expense by approximately 0.04B yen (minimal given low debt levels), but refinancing difficulty could force asset liquidation or constrain operations. The structural mismatch between asset duration (receivables average 340 days) and liability duration (debt predominantly short-term) creates funding risk if operating cash flow disappoints.
(1) Profitability Improvement Without Cash Conversion: The company achieved operating profit growth of +13.3% exceeding revenue growth of +2.5%, demonstrating operational leverage and margin expansion to 3.9% from 3.5% YoY. This profit improvement is driven by Chemical segment stability with new municipal contracts and Functional Materials segment growth in overseas orders. However, the severe receivables buildup (DSO 340 days, receivables +5.2B yen) raises fundamental concerns about whether reported earnings are converting to cash. Until operating cash flow data confirms cash generation, profit growth should be viewed cautiously as potentially accrual-based rather than cash-backed. This characteristic suggests earnings quality warrants close monitoring despite favorable profit trends.
(2) Balance Sheet Transformation Through Securities Holdings: Investment securities increased +27.3% to 17.6B yen, now representing 21% of assets and generating 0.5B yen in dividend income (27% of ordinary income). This portfolio evolution has shifted the company's earnings mix toward investment income rather than pure trading margins. Comprehensive income of 4.4B yen (2.4x net income) reflects substantial unrealized gains on these holdings, contributing +2.6B yen to accumulated other comprehensive income. This transformation creates a hybrid business model with trading operations (core Chemical and Functional Materials segments) supplemented by investment portfolio returns. The strategic implication is that total shareholder returns increasingly depend on securities market performance alongside operational execution, introducing volatility but also diversification.
(3) Working Capital as Critical Value Unlock Opportunity: The estimated 340-day DSO versus industry median of 74 days represents the company's most significant operational inefficiency and largest potential value creation opportunity. If management successfully reduces receivables to industry-standard levels, approximately 30-35B yen in cash could be released from working capital (calculated as the difference between current 46.8B yen receivables and an industry-standard level of 12-15B yen based on 74-day DSO). This cash release would dramatically improve FCF generation, enable debt reduction or increased shareholder returns, and lift ROIC from 4.7% toward higher single-digit or double-digit levels. The near-term investment case hinges substantially on whether management can demonstrate progress on receivables management, as this single factor dominates capital efficiency and cash conversion potential.
This report was automatically generated by AI integrating XBRL earnings data and PDF presentation materials as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI analysis of PDF earnings presentation
Soda Nikka Co., Ltd. (8158) delivered higher revenue and earnings for the third quarter of the fiscal year ending March 2026, with net sales of JPY 501.41 billion (+2.5%), operating income of JPY 1.935 billion (+13.3%), and quarterly net income attributable to owners of the parent of JPY 1.848 billion (+0.1%). In the Chemicals segment, municipal water treatment agents, inorganic chemicals for the electronics industry, and toiletry-related products for the daily necessities industry performed well. In the Functional Materials segment, overseas orders for packaging-related equipment and sales of composite films for food packaging expanded. In the Other segment, Moris’s sewn sundries were strong, while chemical sales in Indonesia struggled. The full-year outlook is maintained at net sales of JPY 705 billion, operating income of JPY 2.34 billion, and net income of JPY 2.3 billion. Dividends are planned at JPY 20 for both the interim and year-end, totaling JPY 40 for the year (with a normalized payout ratio above 40%).
The Chemicals segment recorded higher revenue and profit on increased soda-related chemicals for electronics and new municipal orders for aluminum compounds (net sales JPY 334.56 billion/segment profit JPY 2.924 billion). The Functional Materials segment posted higher revenue and profit, supported by overseas orders for packaging-related equipment and strong sales of composite films for food packaging (net sales JPY 106.95 billion/segment profit JPY 0.635 billion). Although growth in quarterly net income attributable to owners of the parent narrowed (+0.1%) due to reduced gains on sales of marketable securities, the earnings growth trajectory remains intact. The company continues its policy of normalizing a dividend payout ratio of 40% or more and will execute shareholder returns in line with the medium-term plan “Go forward STAGE3.”. The full-year forecast remains unchanged from the initial outlook, maintaining expectations for higher revenue and earnings premised on stable chemical market conditions and steady trading.
For the full year, with chemical market conditions expected to remain stable, trading across the Chemicals segment overall is projected to remain firm. Through the third quarter, progress rates are 71.1% for net sales and 82.7% for operating income, indicating steady advancement. In the fourth quarter, orders for municipal water treatment agents, inorganic chemicals for the electronics industry, and toiletry-related products for the daily necessities industry are expected to remain robust.
No change from the initial full-year guidance. The company forecasts net sales of JPY 705 billion (+8.2%), operating income of JPY 2.34 billion (+10.9%), ordinary income of JPY 2.67 billion (+7.8%), and net income attributable to owners of the parent of JPY 2.3 billion (+4.8%). Dividends are planned at JPY 20 for both the interim and year-end, totaling JPY 40 for the year, maintaining the policy of normalizing a payout ratio of 40% or more. To achieve the medium-term plan “Go forward STAGE3,” the company will promote earnings expansion in each segment and strengthen shareholder returns.
Expand new municipal orders for water treatment agents and strengthen transactions in inorganic chemicals for the electronics industry within the Chemicals segment. Expand overseas orders for packaging-related equipment and reinforce sales of composite films for food packaging within the Functional Materials segment. Expand orders for toiletry-related products for daily necessities and pet products. Strengthen the earnings base by expanding transactions in sewn sundries at domestic consolidated subsidiary Moris. Normalize a dividend payout ratio of 40% or more and enhance shareholder returns in line with the medium-term plan “Go forward STAGE3”.
Weak chemical sales at the Indonesian overseas consolidated subsidiary due to economic slowdown and changes in the competitive environment. Volatility risk in chemical market conditions. Risk of a decline in transportation equipment applications for glass short fibers within the Functional Materials segment. Impact on net income due to fluctuations in non-operating income such as gains on sales of marketable securities. Uncertainties in performance outlook and potential variability due to changes in internal and external conditions as stated in the disclaimers.